Auxilium Pharmaceuticals programs to merge with QLT Auxilium Pharmaceuticals.

Auxilium Pharmaceuticals programs to merge with QLT Auxilium Pharmaceuticals, Inc. , a integrated specialty biopharmaceutical company fully, and QLT Inc. , a Canadian-based biotechnology company centered on developing innovative orphan ophthalmology items, today announced they have entered right into a definitive contract under which Auxilium programs to merge with QLT visitar web tadalafilo.org . The transaction is likely to drive shareholder worth creation by accelerating Auxilium's ongoing transformation right into a leading diversified UNITED STATES specialty biopharmaceutical company. Due to the merger, Auxilium expects with an expanded corporate system that includes concentrated investments in analysis and advancement and the continued quest for services and M&A because of cost and taxes synergies.

Other entries from category "ozone therapy":

Random entries